Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Seer Inc

SEER
Current price
1.97 USD -0.02 USD (-1.01%)
Last closed 2.04 USD
Company seer.bio
ISIN US81578P1066
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 118 966 184 USD
Yield for 12 month +1.03 %
1Y
3Y
5Y
10Y
15Y
SEER
21.11.2021 - 28.11.2021

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Address: 3800 Bridge Parkway, Redwood City, CA, United States, 94065

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.00 USD

P/E ratio

Dividend Yield

Current Year

+14 170 000 USD

Last Year

+15 182 000 USD

Current Quarter

+3 949 000 USD

Last Quarter

+3 942 000 USD

Current Year

+7 055 000 USD

Last Year

+7 027 000 USD

Current Quarter

+1 974 000 USD

Last Quarter

+1 848 000 USD

Key Figures SEER

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -93 925 000 USD
Operating Margin TTM -587.20 %
Price to Earnings
Return On Assets TTM -15.59 %
PEG Ratio
Return On Equity TTM -23.91 %
Wall Street Target Price 3.00 USD
Revenue TTM 14 170 000 USD
Book Value 5.54 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -9.90 %
Dividend Yield
Gross Profit TTM 7 055 000 USD
Earnings per share -1.39 USD
Diluted Eps TTM -1.39 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SEER

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History SEER

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio TTM
Last Split Date

Stock Valuation SEER

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.11
Price Sales TTM 8.40
Enterprise Value EBITDA 1.72
Price Book MRQ 0.36

Financials SEER

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SEER

For 52 weeks

1.56 USD 2.63 USD
50 Day MA 2.00 USD
Shares Short Prior Month 1 935 874
200 Day MA 2.04 USD
Short Ratio 8.03
Shares Short 1 972 727
Short Percent 3.67 %